| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer?
|
Grinda, T.
|
|
|
8 |
5 |
p.
|
artikel
|
| 2 |
Artificial intelligence as an adjunct tool for breast oncologists – are we there yet?
|
Schlam, I.
|
|
|
8 |
5 |
p.
|
artikel
|
| 3 |
A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology
|
Al-Batran, S.-E.
|
|
|
8 |
5 |
p.
|
artikel
|
| 4 |
Association between post-operative hPG80 (circulating progastrin) detectable level and worse prognosis in glioblastoma
|
Doucet, L.
|
|
|
8 |
5 |
p.
|
artikel
|
| 5 |
Authors’ reply—Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not
|
Zwart, W.H.
|
|
|
8 |
5 |
p.
|
artikel
|
| 6 |
Comment on redefining authorship in the era of artificial intelligence: balancing ethics, transparency, and progress
|
Scimeca, M.
|
|
|
8 |
5 |
p.
|
artikel
|
| 7 |
Corrigendum to ‘Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up’
|
van Herpen, C.
|
|
|
8 |
5 |
p.
|
artikel
|
| 8 |
Defining a role for systemic chemotherapy in local and advanced appendix adenocarcinoma ☆
|
Strach, M.C.
|
|
|
8 |
5 |
p.
|
artikel
|
| 9 |
Dignity of Science and the use of ChatGPT as a co-author
|
Scimeca, M.
|
|
|
8 |
5 |
p.
|
artikel
|
| 10 |
Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not.
|
Socha, J.
|
|
|
8 |
5 |
p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
8 |
5 |
p.
|
artikel
|
| 12 |
Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain
|
Roitberg, F.
|
|
|
8 |
5 |
p.
|
artikel
|
| 13 |
From N-of-one to series of exceptional responders: unlocking the mystery of outliers in oncology
|
Rodriguez, J.E.
|
|
|
8 |
5 |
p.
|
artikel
|
| 14 |
Genomic characterization of thymic epithelial tumors in a real-world dataset
|
Kurokawa, K.
|
|
|
8 |
5 |
p.
|
artikel
|
| 15 |
Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
|
Le Rhun, E.
|
|
|
8 |
5 |
p.
|
artikel
|
| 16 |
Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapy
|
Hu, Y.-J.
|
|
|
8 |
5 |
p.
|
artikel
|
| 17 |
Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial
|
Grassi, E.
|
|
|
8 |
5 |
p.
|
artikel
|
| 18 |
Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?
|
Aldea, M.
|
|
|
8 |
5 |
p.
|
artikel
|
| 19 |
Precision medicine’s new frontier: integrating palliative care at the right time
|
Sampetrean, A.
|
|
|
8 |
5 |
p.
|
artikel
|
| 20 |
Prognostic value of comorbidities in older patients with cancer: the ELCAPA cohort study
|
Benderra, M.-A.
|
|
|
8 |
5 |
p.
|
artikel
|
| 21 |
Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16
|
Yasui, H.
|
|
|
8 |
5 |
p.
|
artikel
|
| 22 |
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe
|
Hofman, P.
|
|
|
8 |
5 |
p.
|
artikel
|
| 23 |
Redefining authorship in the era of artificial intelligence: balancing ethics, transparency, and progress
|
Ergun, Y.
|
|
|
8 |
5 |
p.
|
artikel
|
| 24 |
Re: Safety and efficacy concerns of long-acting GnRH agonist trigger for ovulation induction in oncological patients undergoing oocyte cryopreservation: a call for caution and further investigation
|
Massarotti, C.
|
|
|
8 |
5 |
p.
|
artikel
|
| 25 |
Response to letter entitled: letter comments on: Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation
|
Gosney, J.R.
|
|
|
8 |
5 |
p.
|
artikel
|
| 26 |
Safety and efficacy concerns of long-acting GnRHa trigger for ovulation induction in oncological patients undergoing oocyte cryopreservation: a call for caution and further investigation
|
Ingold, C.
|
|
|
8 |
5 |
p.
|
artikel
|
| 27 |
Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies
|
Blay, J.-Y.
|
|
|
8 |
5 |
p.
|
artikel
|
| 28 |
Table of Contents
|
|
|
|
8 |
5 |
p.
|
artikel
|
| 29 |
The paradigm shift to precision oncology between political will and cultural acceptance
|
Rassy, E.
|
|
|
8 |
5 |
p.
|
artikel
|
| 30 |
Tissue navigator, an important position in the Pathology laboratory in the Precision Medicine era
|
Tavora, F.
|
|
|
8 |
5 |
p.
|
artikel
|
| 31 |
Unlocking digitally enabled research in oncology: the time is now
|
Franzoi, M.A.
|
|
|
8 |
5 |
p.
|
artikel
|
| 32 |
Young oncologists’ perspective on the role and future of the clinician-scientist in oncology
|
Lim, K.H.J.
|
|
|
8 |
5 |
p.
|
artikel
|
Tijdschrift beschrijving